When was EndObetes founded?

EndObetes was founded in 2015 and raised its 1st funding round 4 years after it was founded.

Where is EndObetes located?

EndObetes is headquartered in New York City, United States.

Is EndObetes a funded company?

EndObetes is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 17, 2019.

When was the latest funding round of EndObetes?

EndObetes' latest funding was a $***** Grant (prize money) round on Jul 07, 2020, with participation from 1 investor. Its primary sector is Diabetes. In United States, the Diabetes sector has seen $819M in funding in 2026 to date.

Where does EndObetes rank among its competitors?

EndObetes ranks 20th amongst 102 active competitors, of which 29 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Claria Medical, which secured $3.85M in Sep, 2025.

Who are the top competitors of EndObetes?

EndObetes' top competitors include GI Windows, Claria Medical and Fractyl. Among them, Claria Medical secured the most recent funding round in September, 2025.

EndObetes - 2026 Company Profile, Team, Funding & Competitors

Company Details

Endobetes has developed a surgical access tool. The company has developed an endoscopically food delivery solution for treating obesity and diabetes. The solution is fixed in the GI tract to deliver undiluted and undigested food directly to the small intestine similar to the function of a gastric bypass.

Website: endobetes.com
Email ID: *****@endobetes.com
Phone Number: +1 **********

Key Metrics

Founded Year

2015

Location

New York City, United States

Stage

Seed

Latest Funding Round

Grant (prize money), Jul 07, 2020, $*****

Investors

Biotechnology Innovation Organization & 2 more

Ranked

20^th among 102 active competitors

Similar Companies

GI Windows & 118 more

View EndObetes' full profile

EndObetes has raised funding over 3 rounds. Its first funding round was on Jun 17, 2019. Its latest funding round was a Grant (prize money) round on Jul 07, 2020 for $*****. 1 investor participated in its latest round. EndObetes has 3 institutional investors.

Here is the list of recent funding rounds of EndObetes:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 07, 2020	5264969	Grant (prize money)	1258062	3512396	2567205	1186118
Jul 01, 2019	9153700	Seed	9381985	9553129	1228252	9268502
Jun 17, 2019	8444485	Seed	7924530	2483562	MedTech Innovator	6480053

Access funding benchmarks and valuations. Sign up today!

View details of EndObetes's funding rounds and investors

The founders of EndObetes is Marc Bessler.

Here are the details of EndObetes' key team members:

Marc Bessler: Founder of EndObetes.

View details of EndObetes's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of EndObetes include GI Windows, Claria Medical and Fractyl. Here is the list of Top 10 competitors of EndObetes, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	GI Windows 2012, West Bridgewater (United States), Series B	Revolutionizing surgical anastomosis with innovative magnetic technology for less invasive procedures	$92M	GT Healthcare Capital Partners, Sonder Capital ... & 7 others	62/100
2nd	Claria Medical 2017, Mountain View (United States), Series A	Developer of minimally invasive surgical instruments	$8M	National Science Foundation, HHS & 1 others	57/100
3rd	Fractyl 2010, Lexington (United States), Public	Provider of Endoscopic procedure for type - 2 diabetes	$345M	Mithril, Maverick Ventures & 17 others	55/100
4th	ClearCam 2018, Austin (United States), Seed	ClearCam: Improving surgical vision with in-vivo laparoscope lens cleaning	$7.73M	Austin Technology Incubator, Texas Halo Fund ... & 5 others	52/100
5th	Xenocor 2000, Salt Lake City (United States), Early Stage	Provider of Laparoscopic imaging system for surgeries	$10M	GenHenn Capital, Mountain Pacific Venture Partners ... & 2 others	52/100
6th	Endolumik 2020, Morgantown (United States), Seed	Provider of a minimally invasive medical device for laparoscopic surgery	$2.2M	Country Roads Angel Network	47/100
7th	ModaThera 2002, Laguna Niguel (United States), Acquired	Provider of medical devices for obesity treatment and metabolic disease management	-	HealthCor Partners, Endeavour Vision & 5 others	46/100
8th	GT Metabolic Solutions 2020, Saint Michael (United States), Series B	Developer of medical technology intended to revolutionize gastric bypass	$23.2M	Krillion Ventures	46/100
9th	SurgiQuest 2006, City of Orange (United States), Acquired	Products for minimum invasive surgery	$59.1M	iandpdev.com, RC Capital & 7 others	45/100
10th	Morphic Medical 2003, Boston (United States), Unfunded	Developer of medical devices for the treatment of type 2 diabetes and obesity	-	-	45/100
20th	EndObetes 2015, New York City (United States), Seed	Developer of surgical access tool	-	MedTech Innovator, HHS & 1 others	37/100